Related Experiment Videos

S14063: a new potent 5-HT1A receptor antagonist devoid of beta-adrenoceptor blocking properties

H Dabiré¹, R Bajjou, K Chaouche-Teyara

¹INSERM U337, Faculté de Médecine Broussais Hôtel-Dieu, Paris, France.

European Journal of Pharmacology

|October 15, 1991

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Final overall survival results from EORTC 1333/PEACE-3 trial of enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer: results of the EORTC 1333/PEACE-3 trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Aggregatibacter actinomycetemcomitans infection in children: two case reports and a review of the literature.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2024

Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small-cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2023

Oral manifestations of sickle cell disease.

British dental journal·2019

[Dermatomyositis associated with anti-MDA5 antibodies and pneumocystis pneumonia: Two lethal cases].

Annales de dermatologie et de venereologie·2016

See all related articles